Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants
Clinical trial NCT02209506 · TERMINATED
Trial details
- NCT number
- NCT02209506
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2014-09-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.